Streetbeat News

Stock Prices

MOH

Molina Healthcare (NYSE:MOH) has delivered an average annual return of 22.81% over the past 5 years, outperforming the market by 10.13%. A $100 investment in MOH 5 years ago would now be worth $263.71. The company's current market capitalization stands at $20.82 billion.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 8:00 pm

NYCB

New York Community Bancorp Inc (NYSE:NYCB) experienced significant volatility, with shares dropping about 22% following a liquidity and deposit update, executive changes, and analyst downgrades. The company reported an increase in total deposits to $83 billion, total liquidity of $37.3 billion, and announced the appointment of Alessandro DiNello as executive chairman. Moody's downgraded the company's ratings to junk, and analysts from JPMorgan and BofA Securities downgraded the stock with lowered price targets. Additionally, NYCB is seeking financing for a portfolio of residential mortgages and faces a securities fraud lawsuit.

Portfolio Pulse from Adam Eckert

February 07, 2024 | 7:58 pm

FDMT

4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock fell 11.7% to $28.33 after announcing an upsized underwritten public offering of over 6.5 million shares at $29.50 each, plus pre-funded warrants for about 3.6 million shares. The offering, managed by Goldman Sachs & Co. LLC, BofA Securities, Jefferies, and Barclays, aims to raise approximately $300 million before fees and is expected to close on February 9. FDMT does not pay dividends but engages in capital allocation programs.

Portfolio Pulse from Henry Khederian

February 07, 2024 | 7:56 pm

AMZN

GOOG

GOOGL

META

SNAP

Snap Inc's Q4 revenue missed estimates, causing its stock to plummet over 35%. Despite beating earnings per share estimates, analysts remain cautious, awaiting consistent execution. The company faces challenges from infrastructure investments, rising marketing expenses, and competition from larger platforms like Alphabet, Meta Platforms, and Amazon.com. Analysts from JPMorgan, Stifel, Truist Securities, and Oppenheimer provided mixed outlooks, highlighting the need for improved execution and market share recovery.

Portfolio Pulse from Surbhi Jain

February 07, 2024 | 7:55 pm

AMGN

Amgen Inc (NASDAQ:AMGN) reported a 15% increase in Q4 2023 adjusted net profit to $4.71, surpassing the consensus of $4.62, driven by a 20% increase in revenues to $8.2 billion. The growth was partially offset by higher operating expenses. Product sales, including $954 million from the Horizon Therapeutics acquisition, grew 20%. Amgen expects adjusted EPS of $18.90-$20.30 and revenue of $32.4 billion-$33.8 billion. Investors are keen on Amgen's obesity drug data, with Phase 1 and 2 study results expected in 2024. Analysts have adjusted price targets, reflecting various outlooks on the company's performance and potential.

Portfolio Pulse from Vandana Singh

February 07, 2024 | 7:36 pm

AVNW

GLT

HOLO

SNAP

TCS

TGI

YUM

U.S. stocks traded higher with the Dow Jones, NASDAQ, and S&P 500 all seeing gains. Yum! Brands reported disappointing Q4 results, missing sales and EPS estimates. MicroCloud Hologram, Glatfelter Corporation, and Aviat Networks saw significant stock price increases, while Triumph Group, The Container Store Group, and Snap Inc. experienced notable declines. Oil prices rose, while gold remained mostly flat.

Portfolio Pulse from Avi Kapoor

February 07, 2024 | 7:32 pm

CHKP

Analysts have mixed views on Check Point Software Technologies Ltd (NASDAQ:CHKP), with price targets adjusted amidst solid revenue growth and market share concerns. Mizuho maintains a Neutral stance, raising the price target to $160, citing slight revenue growth exceedance and a solid initial outlook for 2024 despite market share loss. Wedbush and Truist express more optimism, raising their price targets to $185 and $175, respectively, highlighting cross-sell opportunities and a positive outlook. Susquehanna is bullish, increasing the target to $200, praising technological leadership. KeyBanc maintains a Sector Weight rating, pointing to valuation and margin pressure.

Portfolio Pulse from Anusuya Lahiri

February 07, 2024 | 7:31 pm

HOOD

Financial analysts have observed a bullish trend in options trading for Robinhood Markets (NASDAQ:HOOD), with 70% of trades showing bullish sentiment. The trading activity suggests a target price range of $9.0 to $15.0 for HOOD over the next three months. Significant trades include both puts and calls, with a notable volume and open interest within the $9.0 to $15.0 strike price range. Robinhood Markets, known for its app-based financial services platform, has seen its stock price increase by 0.56% to $10.84, with a neutral RSI. Analysts from Goldman Sachs and Mizuho have set target prices at $11 and $15, respectively.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 7:30 pm

CHTR

Investors and traders have shown a bearish stance on Charter Communications (NASDAQ:CHTR), as evidenced by recent options trading activity. Benzinga's options scanner revealed 16 unusual trades, with a sentiment split of 31% bullish and 68% bearish. The trades aim for a price range of $170 to $540 for CHTR over the next three months. Analysts have varying opinions on CHTR, with price targets ranging from $280 to $472. The company, a major U.S. cable provider, is currently trading at $290, slightly down by 0.1%.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 7:30 pm

LNG

Cheniere Energy (NYSE:LNG) has delivered an average annual return of 19.42% over the past 5 years, outperforming the market by 6.73% on an annualized basis. A $100 investment in LNG 5 years ago would be worth $244.61 today. The company's current market capitalization stands at $38.18 billion.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 7:30 pm